Zavante Therapeutics

Zavante Therapeutics

Signal active

Organization

Contact Information

Overview

Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.

About

Industries

Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics

Founded

2015

Employees

11-50

Headquarters locations

San Diego, California, United States, North America

Social

Profile Resume

Zavante Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $5.2B in funding across 80 round(s). With a team of 11-50 employees, Zavante Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Zavante Therapeutics, raised $10.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace EJ Ellis- Grosse

EJ Ellis- Grosse

CSO

Funding Rounds

Funding rounds

4

Investors

1

Lead Investors

0

Total Funding Amount

$65.0M

Details

1

Zavante Therapeutics has raised a total of $65.0M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2016Early Stage Venture45.0M

Investors

Zavante Therapeutics is funded by 13 investors.

Investor NameLead InvestorFunding RoundPartners
Zavante Therapeutics-FUNDING ROUND - Zavante Therapeutics45.0M
Global Source Ventures-FUNDING ROUND - Global Source Ventures45.0M
Zavante Therapeutics-FUNDING ROUND - Zavante Therapeutics10.0M
Square 1 Bank-FUNDING ROUND - Square 1 Bank10.0M